Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Kinase pathways" refers to the intricate signaling networks orchestrated by kinases, a vast family of enzymes responsible for the transfer of phosphate groups (phosphorylation) to target proteins. This post-translational modification activates or deactivates proteins, enabling rapid and reversible regulation of virtually all cellular processes, including cell proliferation, survival, differentiation, metabolism, and immune responses. Dysregulation of these pathways is a hallmark of many diseases, particularly cancer, and constitutes a major therapeutic strategy via kinase inhibitors. However, this is not a singular molecular target but rather a collective label for any signaling cascade propagated primarily by kinases.
The dominant mechanism is inhibition of kinase activity, typically either ATP-competitive inhibition (blocking the kinase catalytic site) or allosteric inhibition, with some monoclonal antibodies blocking extracellular portions of receptor kinases. Multi-kinase or pathway targeting—blocking several signaling nodes simultaneously—is employed to overcome redundancy and resistance.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Kinase pathways (null).